Cost-effectiveness of Ritalin™ versus Adderall™ for first-line treatment of attention deficit/hyperactivity disorder (ADHD) in children

被引：0
|
作者：
Narayan, S [1 ]
Hay, JW [1 ]
机构：
[1] Univ So Calif, Sch Pharm, Los Angeles, CA 90089 USA
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62235-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：275 / 276
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents
    Iskedjian, M
    Maturi, B
    Walker, JH
    Einarson, TR
    Khattak, S
    Carter, G
    VALUE IN HEALTH, 2003, 6 (03) : 275 - 275
  • [2] THE COST-EFFECTIVENESS OF GUANFACINE EXTENDED RELEASE (GXR) VERSUS ATOMOXETINE (ATX) FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS
    Erder, M.
    Chen, K.
    Wu, E. Q.
    Hodgkins, P.
    Sikirica, V
    VALUE IN HEALTH, 2011, 14 (03) : A192 - A192
  • [3] Safety and efficacy of Adderall in children newly diagnosed with attention deficit hyperactivity disorder (ADHD)
    Ahmann, P
    Theye, F
    Waltonen, S
    Campbell, R
    Guenter, S
    Mundi, P
    Musser, C
    Shen, SJ
    Berg, R
    NEUROLOGY, 1999, 52 (06) : A154 - A154
  • [4] A comparison of Ritalin and Adderall: Efficacy and time-course in children with attention-deficit/hyperactivity disorder
    Pelham, WE
    Aronoff, HR
    Midlam, JK
    Shapiro, CJ
    Gnagy, EM
    Chronis, AM
    Onyango, AN
    Forehand, G
    Nguyen, A
    Waxmonsky, J
    PEDIATRICS, 1999, 103 (04) : e43
  • [5] Effectiveness and tolerability of Adderall in adults with attention deficit hyperactivity disorder
    Spencer, TJ
    Wilens, T
    Biederman, J
    Kagan, J
    Bearman, SK
    NEUROLOGY, 1999, 52 (06) : A288 - A288
  • [6] Cost-effectiveness of clinically proven treatment strategies for attention-deficit/hyperactivity disorder (ADHD) in five jurisdictions
    Schlander, M.
    Schwarz, O.
    Hakkaart-van Roijen, L.
    Jensen, P. S.
    Persson, U.
    Santosh, P. J.
    Trott, G. E.
    VALUE IN HEALTH, 2006, 9 (06) : A312 - A312
  • [7] Cost-effectiveness of dexamphetamine and methylphenidate for the treatment of childhood attention deficit hyperactivity disorder
    Donnelly, M
    Haby, MM
    Carter, R
    Andrews, G
    Vos, T
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2004, 38 (08): : 592 - 601
  • [8] Cost-effectiveness of clinically proven treatment strategies for attention-deficit/hyperactivity disorder (ADHD): Impact of coexisting conditions
    Schlander, M.
    Schwarz, O.
    Foster, E. M.
    Hakkaart-van Roijen, L.
    Jensen, P. S.
    Persson, U.
    Santosh, P. J.
    Trott, G. E.
    VALUE IN HEALTH, 2006, 9 (06) : A309 - A309
  • [9] Cost-Effectiveness and Cost Utility of Treatment of Attention-Deficit/Hyperactivity Disorder: A Systematic Review
    Dijk, Hermien H.
    Wessels, Lisa M.
    Constanti, Margaret
    van den Hoofdakker, Barbara J.
    Hoekstra, Pieter J.
    Groenman, Annabeth P.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2021, 31 (09) : 578 - 596
  • [10] Cost-effectiveness of pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: Qualitative synthesis of scientific evidence
    Catala-Lopez, Ferran
    Ridao, Manuel
    Sanfelix-Gimeno, Gabriel
    Peiro, Salvador
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2013, 6 (04): : 168 - 177
12345